(1 - 21 von 22
)
Are So-Called 'Liquid Biopsy' Cancer Tests The Real Deal?in.news.yahoo.com › called-liquid-biopsy-cancer-tes...
in.news.yahoo.com
· While Pathway Genomics cites the cancer research of Dr. Max Diehn as evidence, Diehn himself told CBS News the tests likely can't do what ...
Guardian: AI program could check blood for signs of lung cancer | Lung cancer |...
Scientists hope that if software p… trials it could boost screening rates
Rapper Kontra K mit neuem Album - »Die Angst vor dem Tod treibt ...www.bild.de › rapper › kontra-k-im-bild-interview bild.html
www.bild.de
· Es geht auch ohne Dissen.Vor zwei Jahren schoss Kontra K (29, mit bürgerlichem Namen Max Diehn) mit seinem Album „Labyrinth“ erstmals auf ...
UCLA Bioinformatics Lecture with Max Diehn, M.D., Ph.D., Stanford...
uccai.ctsi.ucla.edu
UCLA Bioinformatics | An Interdepartmental Graduate Program. Seminar Series Co-sponsored by QCBio & CTSI. Speaker: Max Diehn, MD, PhD. Assistant Professor, Department of Radiation Oncology Stanford University. This seminar received support from the NIH NCATS UCLA CTSI Grant Number UL1TR
Blood tests, microbes, immunotherapy and more: AACR 2017's hottest...
news.cancerresearchuk.org
At AACR 2017, thousands of doctors and scientists gathered to share progress in cancer research. Read about the hottest topics of the conference.
CBS News investigation: Liquid biopsy giving false sense of security...
www.cbsnews.com
Pathway Genomics claims its liquid biopsy can detect cancer before patient shows symptoms - but expert says that promise is "years away"
AI program could check blood for signs of lung cancer | TANAKA ...tanaka-preciousmetals.com › news-cred
tanaka-preciousmetals.com
· That system has its flaws, though, according to Max Diehn, who studies radiation oncology at Stanford University. He said only 5% of people ...
A New Way to Attack Early Metastatic Disease - Johns Hopkins Medicine
clinicalconnection.hopkinsmedicine.org
DiscoveryJanuary 22, 2016
NCRI Cancer Conference 2016: Day 2 – blood tests, virus treatments,...
news.cancerresearchuk.org
Read our highlights from day 2 of the NCRI Cancer Conference, including blood tests for cancer, viruses as cancer treatments, and prizes.
Foresight Diagnostics Raises $12.5M in Series A to Commercialize ...www.genomeweb.com › ... › Business News
www.genomeweb.com
· ... unmet need for how we clinically manage oncology patients," company cofounder and Stanford researcher Max Diehn said in a statement.
ASTRO awards $ to four cancer research - EurekAlert!
www.eurekalert.org
— Recipients chosen for are Roberto Diaz, M.D., Ph.D., Max Diehn, M.D., Ph.D., and Aaron C. Spalding, M.D., Ph.D. › news-...
Stanford researchers develop new test to spot traces of early lung...
abc7news.com
The blood test can spot the traces of early lung cancer, long before it might be caught by an imaging test.
Can A Simple Blood Test Really Spot Cancer Early? Don't Bet ...
www.buzzfeednews.com
— ... if a new test is a useful screening test,” Max Diehn, an assistant professor of radiation oncology at Stanford, told BuzzFeed News. › c...
Cancer Test Featured on 'Keeping Up With the Kardashians ...
www.usmagazine.com
— Max Diehn, a cancer researcher at Stanford University, however, tells CBS News that “we're still years away from that possibility.” During the ... › news
Stanford University Study Shows Early Detection of CTCs in NSCLC ...www.technologynetworks.com › ... › News
www.technologynetworks.com
· ... from early stage non-small cell lung cancer (NSCLC) patients obtained in collaboration with Dr. Max Diehn's lab at Stanford University.
Fluxion Biosciences reports first study results from early stage...
www.news-medical.net
— Max Diehn's lab at Stanford University. CTCs are cells that disseminate from primary tumors and contribute to the spread of the disease to other ... › news
Foresight Diagnostics Commercializing PhasED-seq Liquid ...
www.precisiononcologynews.com
— Called phased variant enrichment and detection sequencing, or PhasED-seq, the technique was developed by Stanford researchers Max Diehn and ... › ...
Lung Cancer Recurrence, Predictable at Last? - Inside Science
www.insidescience.org
— ... is only partially successful, said Max Diehn, a radiation oncologist at Stanford University who led the team that developed the test. › news
Urine test may revolutionize bladder cancer detection - Healio
www.healio.com
— Photo of Max Diehn. Maximilian Diehn. A novel urine test may detect bladder cancer earlier than available methods, according to study ... › news › hematology-oncology
sortiert nach Relevanz / Datum